Accelerating New Drug Indication Launch Through Strategic Thought Leader Engagement

A top 10 pharmaceutical company was expecting early approval for a new use of a drug to treat obstructive sleep apnea (OSA). However, the medical team was lacking knowledge about the experts in this indication, and needed a comprehensive, up-to-date list of key healthcare professionals (HCPs) both in the U.S. and globally.

To prepare for the launch, the medical team engaged with H1 to discover and connect with experts in the field. They were able to gather comprehensive data to strategically identify key HCPs to ensure they were prepared for the launch.

As a result of H1’s analysis and partnership, the team achieved early engagements with 383 key HCPs, leading to an ROI of $3.8M.

Discover all the strategic details, action plan, and results by downloading the full case study today.